Articles tagged with Cancer Treatments
Researchers at Linköping University have developed a strategy to discover disease progression at its earliest phase by analyzing T-cells. The study found that specific genes can serve as early disease markers, even before symptoms appear.
Researchers at Children's Hospital of Philadelphia identified a crucial change in a single DNA base that both predisposes children to aggressive neuroblastoma and drives disease progression. This discovery may lead to novel therapies for the complex and deadly disease.
Researchers aim to advance understanding of intrinsically disordered proteins controlling cellular behavior and potential cures for devastating diseases such as Parkinson's and Alzheimer's. The initiative seeks to raise awareness about the societal impacts of these understudied proteins and develop new therapies.
A phase III trial showed that sorafenib modestly increased progression-free survival (PFS) and disease control rate in NSCLC patients, but did not impact overall survival. The study also found that EGFR mutation positive patients receiving sorafenib had significantly longer OS and PFS.
A new blood test for prostate cancer significantly improves detection of aggressive cancer, reducing false positives and unnecessary biopsies. The STHLM3 test analyzes protein markers, genetic data, and clinical information to detect cancers in men with low PSA values.
The Integrated Mathematical Oncology Department at Moffitt Cancer Center has been awarded a $10.4 million grant from the National Cancer Institute to develop new strategies to prevent and treat cancer by exploiting Charles Darwin's concept of natural selection.
Scientists have molecularly characterized two types of the second most common kidney cancer, papillary renal cell carcinoma (PRCC), which accounts for 15-20% of kidney cancer cases. The study reveals distinct molecular differences between Type 1 and 2 PRCC, as well as three subtypes of Type 2, each with varying molecular alterations. T...
A new method using sound waves can detect cell stiffness changes that could signal disease, such as cancer and autoimmune disorders. The technique uses low-frequency ultrasonic waves to levitate cells and high-frequency ultrasonic waves to measure their stiffness.
Scientists tracked breast cancer development using tumour DNA shed into bloodstream, reflecting genetic changes and treatment response. The study provides proof-of-principle for real-time monitoring of cancer, potentially reducing need for invasive biopsies.
Patient advocates urge medical professionals and policymakers to consider the long-term effects of advanced breast cancer treatments. They highlight the need for accessible therapies that extend patients' lives, while also addressing financial, employment, and family challenges associated with prolonged illness. Experts note that curre...
Researchers at Hiroshima University have discovered that fragments of cancer DNA circulating in the bloodstream can predict the recurrence and spread of liver cancer. This non-invasive method, known as circulating tumor DNA (ctDNA), provides valuable clinical information about the patient's disease progression.
Pfizer announces new scientific abstracts and presentations for XELJANZ (tofacitinib citrate) in rheumatoid arthritis, including safety data, long-term extension studies, and real-world evaluation. The data highlights the efficacy and safety of XELJANZ in treating RA.
The O'Neill Institute's new Hepatitis Policy Project aims to address issues and barriers of access to hepatitis C treatment, particularly among baby boomers who often don't know they're infected. The project seeks to support hepatitis C consumer education and advocacy organizations through policy research.
A novel fusion gene NUP160-SLC43A3 has been identified in skin cancer cells, leading to rapid tumor progression and a significantly shorter duration between symptoms onset and hospital visit. This discovery has potential implications for new diagnostic and therapeutic approaches for angiosarcoma.
Research at the University of Warwick suggests that cognitive behavioural therapies (CBT) can be moderately to strongly effective in tackling insomnia in patients with long-term pain. The study also found improved sleep results in decreased depression, fatigue, and pain. However, electronic delivery methods were less effective.
Rates of kidney failure caused by multiple myeloma have declined over the past decade, with a 20% reduction from 2001-2002 to 2009-2010. ESRD patients with multiple myeloma are also living longer and experiencing a decline in mortality within 3 years after initiating dialysis.
Scientists at The Wistar Institute have discovered how the SPOP gene suppresses tumor growth through induced senescence. When the gene is functioning properly, it acts as a tumor suppressor and induces senescence in cells.
Premature birth can be lifesaving with TPN, but it also causes liver damage. Dr. Ajay Jain is studying ways to prevent TPN-related complications in newborns.
New risk profiling approach aims to detect GI cancers, such as oesophageal adenocarcinoma, in early stages. The five-tier strategy involves lifestyle changes, non-invasive testing, and genetic analysis to tailor screening and prevention options for each individual.
A new analysis reveals that cancer diagnoses lead to significant declines in employment probability, hours worked, and income for American adults. Working-age men experience the most pronounced effects, with annual labor market earnings dropping by almost 40% within two years after diagnosis.
A new study reveals that cancer diagnoses lead to decreases in working hours and incomes, with effects primarily felt by male survivors. Total family income also declines, but recovers within four years after diagnosis.
Researchers at Stowers Institute have discovered a protein complex called SESAME that links glycolysis to chromatin modification, suggesting a potential target for detecting and treating cancers. The study's findings may also shed light on the relationship between cellular metabolism and gene expression in humans.
Researchers have discovered a new function of Histone H1 that helps summon repair proteins, leading to improved understanding of how cells protect and repair DNA damages. This discovery may eventually result in targeted treatments for diseases such as cancer and immune deficiency syndrome.
A multi-center trial found that therapy dogs can reduce anxiety levels and improve heart rate stability in children with cancer, as well as their parents. The study provides the first solid data on the psychosocial benefits of animal-assisted interventions for pediatric cancer patients.
Biotech expert Mitchell Finer shares his experiences and strategies for achieving commercial success, including the importance of clinical data and access to capital. He also discusses the growth of companies like bluebird bio and Cell Genesys, and the potential for gene therapy to revolutionize treatment options.
Researchers have created a new material combining nanodiamonds, gutta-percha, and amoxicillin to strengthen root canal fillings and kill bacteria. The material shows promise in preventing re-infections and improving current therapies.
New study reveals that histone deacetylase 6 inhibition improves the ability of oncolytic herpes simplex virus type 1 to kill glioma cells. HDAC inhibitors increase viral trafficking to the nucleus, leading to increased replication and tumor cell death.
Researchers identified key metabolic changes that occur in patients with myeloma and those at risk of developing the disease. The findings suggest a potential drug target to prevent progression from benign MGUS to cancerous myeloma.
Researchers have discovered a link between Diamond-Blackfan anaemia and increased cancer susceptibility, using a new animal model that recapitulates key characteristics of the disease. The study found that patients with DBA are predisposed to lymphomas and solid tumours due to mutations in the RPL11 protein.
Researchers have discovered a new gene, snoRNA42, linked to an increased risk of bowel cancer recurrence and shortened survival. This gene may serve as a reliable biomarker for selecting high-risk patients who can benefit from personalized treatments.
Patients with lower household income below $50,000 had 32% lower odds of participating in clinical trials compared to higher income patients. The study found that trial participation decreased as annual household income decreased from $50,000 or higher to between $20,000 and $49,999 and to less than $20,000.
A study found that a specific gene signature called MG5 can divide intermediate-risk rhabdomyosarcoma patients into two separate risk groups. Those with high MG5 scores had poorer survival outcomes and were seven times more likely to die of the disease.
Primary care providers should screen men aged 45 and older with a digital rectal exam (DRE) and prostate-specific antigen (PSA) test. If the patient is asymptomatic, a 5-year screening interval may be considered.
A recent study by researchers at King's College London found that general practices using the urgent referral pathway (two-week wait system) have lower cancer mortality rates compared to those that rarely use this pathway. Increasing its use could improve patient survival, especially for patients from low-referring practices.
A study by Cancer Research UK and King's College London found that cancers diagnosed at a later stage have higher mortality rates, with death rates increasing by seven per cent in practices using the two-week referral route least often. Increasing GP cancer awareness could help reduce deaths.
African-American women are more likely to develop aggressive breast cancer subtypes and receive substandard care compared to non-Hispanic white women. Minority women also experience disparities in treatment across all breast cancer stages, with significant differences in diagnosis timing and treatment approaches.
A new pneumatic compression device has been shown to significantly reduce cellulitis episodes in patients with lymphedema, resulting in an 80% decrease. The device also leads to a 37% reduction in lymphedema-related healthcare costs. This study highlights the potential benefits of advanced devices in managing chronic conditions.
Researchers found that patients with advanced cancer are willing to pay more for aspects of a good end-of-life experience compared to healthy older adults. Both groups highly value high-quality healthcare experiences, including being treated with respect and receiving coordinated care. The study suggests that health reform efforts shou...
Disparities in retinoblastoma outcomes exist among children of different ethnicities and socioeconomic statuses, with Hispanic children having a higher percentage of extraocular disease and being more likely to undergo enucleation. Low socioeconomic status is associated with greater risks for advanced disease and poorer ocular outcomes.
Cancer cases worldwide are projected to reach almost 22 million by 2030, with low- and middle-income countries facing unsustainable economic burdens. Effective cancer prevention campaigns have shown promising results in Taiwan, Rwanda, and Brazil, highlighting the importance of rapid implementation of control programs.
The Lancet Oncology Commission highlights the vital role of primary care doctors in preventing, detecting, survivorship, and palliative care. Effective integration between primary and specialist care is crucial to meet the growing demand for cancer care.
The National Institute on Aging has awarded a grant of $3.567M to study mechanisms of Alzheimer's disease, with a focus on immune system cells that cause synapse damage.
Researchers at Harvard University have discovered a molecule that can halt the growth of cancerous AML cells without harming healthy cells. The molecule, cortistatin A, works by inhibiting two specific kinases that play a key role in the growth of AML cells.
Researchers identified distinct characteristics among non-smoking patients with NSCLC, such as lower chronic obstructive pulmonary disease and heart disease rates. Non-smokers also exhibited longer survival periods after diagnosis compared to smokers.
Patients with recurrent lung cancer who undergo a CT-based follow-up program after surgery experience significantly improved post-surgery survival rates. The study analyzed 391 patients and found that the number of patients alive four years after surgery increased from 54% to an estimated 68%.
Researchers identified a mutated POT1 gene in families with multiple tumors, including cardiac angiosarcoma. The finding opens up the possibility of early diagnosis and treatment for family members.
Researchers have identified a key role for the WWOX gene in suppressing cancer development. Lower levels of WWOX are associated with more aggressive and treatment-resistant cancers. The study suggests that targeting the enzyme activity of WWOX could influence cancer cell properties.
A new UCLA study reveals that Alzheimer's disease consists of three distinct subtypes, each requiring targeted research and potential new treatments. The cortical subtype appears to be fundamentally different from the other two, suggesting different causes and optimal treatment approaches.
Researchers discovered that antidepressant amitriptyline increases FGF2 mRNA expression in astrocytes through RTK activation. This signaling cascade could guide the development of novel antidepressants with new mechanisms. The study expands on previous findings, identifying EGR1 as a necessary protein for FGF2 expression.
Researchers at Mayo Clinic's Florida campus have been awarded a $13.3 million grant to conduct a national, phase II clinical trial testing the ability of a folate receptor alpha vaccine to prevent recurrence of triple-negative breast cancer following initial treatment. The vaccine was designed by Dr. Keith Knutson and exploits the need...
Scientists have identified a FOXC1 gene that causes more aggressive cancer in AML patients. When switched on in blood cell tissue, it stunts the development of blood cells and stops them maturing into normal specialized blood cells, leading to faster cancer growth.
Researchers at Nanjing University have discovered new epigenetic markers for colorectal cancer, which may offer a new approach for treatment. The study found that heterochromatin protein HP1γ was critical for CRC cell proliferation and could be specially regulated by miR-30a.
Researchers discovered that Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in tip and stalk cells, making it a promising therapeutic target for cancer treatment and eye diseases.
Research suggests a treatment that boosts the immune system could improve liver failure treatment outcomes. The therapy uses an immune-boosting molecule called CSF-1 to trigger natural defence mechanisms in the liver.
The International Association for the Study of Lung Cancer has released new data for the TNM classification of lung cancer, which will inform the Eighth Edition of the staging manual. The new database includes 94,708 patients diagnosed worldwide from 1999-2010 and analyzes tumor size, lymph node involvement, and metastatic status.
A new model for preventing and treating obesity in the United States has been proposed, integrating healthcare with community resources. The model centers on individual patients and family engagement, restructuring clinical services to address stigmatization and promoting behavioral changes.
A new study has found that children with coeliac disease react to the same key toxic proteins in gluten as adults, suggesting a potential breakthrough in treatments. The research supports the use of existing treatments and diagnostic tests for adults with coeliac disease for children.
The Mayo Clinic Cancer Center has been awarded a Specialized Program of Research Excellence (SPORE) grant to study the genetic basis of multiple myeloma and develop novel therapies.
Researchers at Johns Hopkins Medicine analyzed survival statistics of 1,298 men with low-risk prostate tumors and found that only two died of prostate cancer after 15 years, while three developed metastatic disease. This suggests that carefully selected patients in active surveillance programs are unlikely to be harmed by their disease.
A 10% increase in wages leads to a 5% drop in smoking rates among male workers with low education levels. Increasing the minimum wage could improve quitting rates for smokers and has significant health benefits.